<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">Human-to-human transmission of SARS-CoV-2 is primarily via respiratory droplets and by direct contact with infected people and indirect contact with contaminated surfaces and objects [
 <xref ref-type="bibr" rid="CR3">3</xref>]. The mean incubation period of SARS-CoV-2 infection varies from 5 to 6 days and the range 1–14 days [
 <xref ref-type="bibr" rid="CR3">3</xref>]. All age groups of humans are susceptible to SARS-CoV-2 infection but at particularly higher risk are the aged, immunocompromised individuals, and people with chronic underlying diseases. The disease manifests as a flu-like (respiratory) illness characterized by fever, chills, sore throat, dry cough, expectoration, dyspnoea, fatigue, headache, myalgia or arthralgia, and less commonly hemoptysis, conjunctival congestion and gastrointestinal tract involvement i.e. nausea or vomiting and diarrhoea [
 <xref ref-type="bibr" rid="CR3">3</xref>]. The case fatality rate (CFR) of COVID-19 has been increasing and is currently higher than what was earlier reported (Table 
 <xref rid="Tab1" ref-type="table">1</xref>) [
 <xref ref-type="bibr" rid="CR5">5</xref>]. 
</p>
